Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter August 31, 2016

Evaluation of an automated chemiluminescent immunoassay for salivary cortisol measurement. Utility in the diagnosis of Cushing’s syndrome

  • Esteban M. Repetto EMAIL logo , Diego Gonzalez , Dario Jacobsen , Fernando Smithuis , Juan Jamardo , Mariel Cano , Claudio Aranda , Adriana Oneto , Gabriela Berg and Bibiana Fabre

Corresponding author: Esteban M. Repetto, PhD, Junin 956 (C1113AAD) Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Bioquímica Clínica, Buenos Aires, Argentina, Phone: +54 11 5950 8654

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This study was supported by a grant from the University of Buenos Aires, Argentina (UBACYT: 20020010041; 2012–2015).

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Fabre B, Maccallini G, Oneto A, Gonzalez D, Hirschler V, Aranda C, et al. Measurement of fasting salivary insulin and its relationship with serum insulin in children. Endocr Connect 2012;1:58–61.10.1530/EC-12-0024Search in Google Scholar PubMed PubMed Central

2. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, et al. The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008;93:1526–40.10.1210/jc.2008-0125Search in Google Scholar PubMed PubMed Central

3. Jezova D, Hlavacova N. Endocrine factors in stress and psychiatric disorders: focus on anxiety and salivary steroids. Ann N Y Acad Sci 2008;1148:495–503.10.1196/annals.1410.050Search in Google Scholar PubMed

4. Deutschbein T, Petersenn S. Screening for Cushing’s syndrome: new immunoassays require adequate normative data. Horm Metab Res 2013;45:118–23.10.1055/s-0032-1331745Search in Google Scholar PubMed

5. Inder WJ, Dimeski G, Russell A. Measurement of salivary cortisol in 2012 – laboratory techniques and clinical indications. Clin Endocrinol (Oxf) 2012;77:645–51.10.1111/j.1365-2265.2012.04508.xSearch in Google Scholar PubMed

6. CLSI, Protocols for Determination of Limits of Detection and Limits of Quantitation, Approved Guideline (EP17-A). Wayne, PA, USA: The National Committee for Clinical Laboratory Standards (NCCLS), 2004.Search in Google Scholar

7. Miller R, Plessow F, Rauh M, Groschl M, Kirschbaum C. Comparison of salivary cortisol as measured by different immunoassays and tandem mass spectrometry. Psychoneuroendocrinology 2013;38:50–7.10.1016/j.psyneuen.2012.04.019Search in Google Scholar PubMed

8. Beko G, Varga I, Glaz E, Sereg M, Feldman K, Toth M, et al. Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin Chim Acta 2010;411:364–7.10.1016/j.cca.2009.11.033Search in Google Scholar PubMed

9. Hansen AM, Garde AH, Persson R. Sources of biological and methodological variation in salivary cortisol and their impact on measurement among healthy adults: a review. Scand J Clin Lab Invest 2008;68:448–58.10.1080/00365510701819127Search in Google Scholar PubMed

Received: 2016-7-1
Accepted: 2016-7-22
Published Online: 2016-8-31
Published in Print: 2017-3-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 28.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2016-0585/html
Scroll to top button